406 related articles for article (PubMed ID: 31970660)
1. The Most Severe Stage of Chronic Venous Disease: An Update on the Management of Patients with Venous Leg Ulcers.
Nicolaides AN
Adv Ther; 2020 Feb; 37(Suppl 1):19-24. PubMed ID: 31970660
[TBL] [Abstract][Full Text] [Related]
2. The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease.
Nicolaides AN
Adv Ther; 2020 Feb; 37(Suppl 1):1-5. PubMed ID: 31970659
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF).
Bush R; Comerota A; Meissner M; Raffetto JD; Hahn SR; Freeman K
Phlebology; 2017 Apr; 32(1_suppl):3-19. PubMed ID: 28211296
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
Kakkos SK; Nicolaides AN
Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
[TBL] [Abstract][Full Text] [Related]
5. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.
Lyseng-Williamson KA; Perry CM
Drugs; 2003; 63(1):71-100. PubMed ID: 12487623
[TBL] [Abstract][Full Text] [Related]
6. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
Ulloa JH
Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
[TBL] [Abstract][Full Text] [Related]
7. The social and economic burden of venous leg ulcers: focus on the role of micronized purified flavonoid fraction adjuvant therapy.
Simka M; Majewski E
Am J Clin Dermatol; 2003; 4(8):573-81. PubMed ID: 12862500
[TBL] [Abstract][Full Text] [Related]
8. A Literature Review of Pharmacological Agents to Improve Venous Leg Ulcer Healing.
Kitchens BP; Snyder RJ; Cuffy CA
Wounds; 2020 Jul; 32(7):195-207. PubMed ID: 33166265
[TBL] [Abstract][Full Text] [Related]
9. From skin disorders to venous leg ulcers: pathophysiology and efficacy of Daflon 500 mg in ulcer healing.
Coleridge Smith PD
Angiology; 2003; 54 Suppl 1():S45-50. PubMed ID: 12934756
[TBL] [Abstract][Full Text] [Related]
10. Chronic venous disease and venous leg ulcers: An evidence-based update.
Kelechi TJ; Johnson JJ; Yates S
J Vasc Nurs; 2015 Jun; 33(2):36-46. PubMed ID: 26025146
[TBL] [Abstract][Full Text] [Related]
11. Clinical and cost efficacy of advanced wound care matrices for venous ulcers.
Hankin CS; Knispel J; Lopes M; Bronstone A; Maus E
J Manag Care Pharm; 2012 Jun; 18(5):375-84. PubMed ID: 22663170
[TBL] [Abstract][Full Text] [Related]
12. Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction.
Coleridge-Smith P; Lok C; Ramelet AA
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):198-208. PubMed ID: 15936227
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia.
Cheng Q; Gibb M; Graves N; Finlayson K; Pacella RE
BMC Health Serv Res; 2018 Jun; 18(1):421. PubMed ID: 29880046
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pentoxifylline for chronic venous leg ulcers: study protocol for a multicenter randomized controlled trial in China (ESPECT study).
Chen L; Gao Y; Liu M; Li Q; Han C; Zhao Y; Li B; Xu J; Dai Y; Li P; Li J; Li Y; Ran X
Trials; 2023 Aug; 24(1):491. PubMed ID: 37533132
[TBL] [Abstract][Full Text] [Related]
15. Chronic venous leg ulcers: is topical zinc the answer? A review of the literature.
O'Connor S; Murphy S
Adv Skin Wound Care; 2014 Jan; 27(1):35-44; quiz 45-6. PubMed ID: 24343392
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of micronized purified flavonoid fraction: an overview.
Struckmann JR
J Vasc Res; 1999; 36 Suppl 1():37-41. PubMed ID: 10474049
[TBL] [Abstract][Full Text] [Related]
17. Interventions for helping people adhere to compression treatments for venous leg ulceration.
Weller CD; Buchbinder R; Johnston RV
Cochrane Database Syst Rev; 2013 Sep; (9):CD008378. PubMed ID: 24009097
[TBL] [Abstract][Full Text] [Related]
18. Advanced Stages of Chronic Venous Disease: Evolution of Surgical Techniques and Advantages of Associated Medical Treatment.
Lurie F
Adv Ther; 2020 Feb; 37(Suppl 1):6-12. PubMed ID: 31981107
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.
Gianesini S; De Luca L; Feodor T; Taha W; Bozkurt K; Lurie F
Adv Ther; 2023 Dec; 40(12):5137-5154. PubMed ID: 37768506
[TBL] [Abstract][Full Text] [Related]
20. Early Stages of Chronic Venous Disease: Medical Treatment Alone or in Addition to Endovenous Treatments.
Mansilha A
Adv Ther; 2020 Feb; 37(Suppl 1):13-18. PubMed ID: 31981108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
